Market Report Source

Overview

Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large and diverse—crossing the $33 billion mark in 2006—and employing over 100,000 laboratory workers, and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory analysis usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations.

The purpose of this TriMark Publications report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this global clinical laboratory markets report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers’ original equipment manufacturer (OEM) additional equipment. The emphasis in this analysis is on those companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent labs, physician’s offices and miscellaneous clinics. This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world. Particular attention is paid to those areas of the clinical laboratory instrumentation and reagents sector that are showing the greatest growth or the most innovation.

This report attempts to answer the following questions:

• Which companies are the key players?
• What are the opportunities in clinical laboratory instrumentation and reagent markets?
• What is happening with the information revolution in lab instruments?
• What are the developing trends?
• Where are the new market growth areas?
• What are the most favored lab analysis technology platforms?
• Where is the laboratory analyzer instrument technology taking us?
• How is immunological technology blending with more established laboratory procedures?
• What are the business trends in the IVD industry?

This analysis reviews the market for clinical laboratory instrumentation used in clinical practice. It defines the dollar volume of sales in each major regional market, as well as 25 individual European country markets, and it analyzes the factors that influence the size and the growth of the individual market segments. The report details market sizes and growth rates for the U.S. and world markets. The study surveys some of the leading companies known to be marketing, manufacturing or developing products for the clinical laboratory instrumentation and reagent market for those sectors covered here. Each company is discussed in depth with a section on the history of the company, product lines, business and marketing analysis, and a subjective commentary of the position of the company in its market. The unique benefits of this report are:

• In-depth analysis of the major sectors of the clinical laboratory instrumentation and reagent sectors, their size, growth rates and major drivers.

• Presentation of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.

• Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.

• Examination of new technology platforms in the U.S., Japan and Europe that seek to dominate this mature market, and to identify lead positions and potential future growth areas.

Table of Contents

1. Overview
1.1 Objectives of the Report
1.2 Methodology
1.3 Scope of the Report
1.4 Executive Summary

2. IVD Clinical Laboratory Market
2.1 Introduction
2.2 Independent Clinical Labs
2.2.1 Key Players for Independent Clinical Labs
2.2.2 Quest and LabCorp
2.2.3 Competitive Advantages at Quest and LabCorp
2.2.4 Competitive Disadvantages of Quest and LabCorp
2.2.5 Revenue Growth of Quest and LabCorp
2.2.6 Sector Consolidation
2.2.7 Additional Independent Clinical Laboratories
2.3 Hospital Market
2.3.1 Hospital Market Overview
2.3.2 Hospital Lab Testing Drivers
2.3.3 Evaluation Models of Laboratory Testing
2.3.4 GPOs and IDNs
2.3.5 Distributors
2.3.6 Clinical Lab Testing Suppliers
2.3.7 European Hospital Purchasing Practices
2.3.8 Changes in Hospital Funding
2.3.9 European Group Purchasing
2.4 POL Market
2.5 IVD Industry
2.5.1 Industry Overview
2.5.2 IVD Industry Leading Players Comparison and Review
2.5.3 Biotechnology Reagents and Supplies
2.5.3.1 Vendor Quality Assurance
2.5.3.2 Partnership Support
2.5.3.3 Protecting Supply of Raw Materials
2.5.3.4 Selecting a Second Source for Chemicals
2.5.3.5 Cost Analysis for Reagent Manufacture
2.5.3.6 Outsourcing Production of Reagents
2.5.4 The Fastest Growing IVD Reagent Markets
2.5.5 Automated Instrumentation
2.5.6 High Growth Applications Spur Industry Growth
2.6 Automated Instrument Platforms Evolution
2.7 Reagents and Supplies Market for Clinical Lab Instruments
2.8 Spending for Clinical Laboratory Testing
2.8.1 Reimbursement Pressure
2.8.2 Medicare Part B Spending Trends
2.8.3 Strategies for Revenue Growth

3. IVD Clinical Laboratory Market
3.1 Markets
3.1.1 Global Markets
3.1.2 Global Drivers of Clinical Laboratory Testing
3.1.3 Global Outlook
3.1.4 U.S. Market
3.1.5 European IVD Market
3.1.5.1 German Clinical Laboratory Diagnostic Markets
3.1.5.2 U.K. Clinical Laboratory Testing Diagnostic Market
3.1.5.2.1 U.K. Competitive Analysis
3.1.5.2.2 U.K. Market Access
3.1.5.3 French Clinical Laboratory Diagnostic Testing Market
3.1.5.4 Italian Clinical Laboratory Diagnostic Market
3.1.5.5 Spanish Clinical Laboratory Diagnostic Market
3.1.5.6 Finnish Clinical Laboratory Market
3.1.5.7 Turkish Clinical Laboratory Market
3.1.5.8 Belgium Clinical Laboratory Diagnostic Market
3.1.5.9 Swiss Clinical Laboratory Diagnostic Market
3.1.5.10 Dutch Clinical Laboratory Diagnostic Market
3.1.5.11 Portuguese Clinical Laboratory Diagnostic Market
3.1.5.12 Austrian Clinical Laboratory Diagnostic Market
3.1.5.13 Greek Clinical Laboratory Diagnostic Market
3.1.5.14 Polish Clinical Laboratory Diagnostic Market
3.1.5.15 Romanian Clinical Laboratory Diagnostic Market
3.1.5.16 Czech Republic Clinical Laboratory Diagnostic Market
3.1.5.17 Swedish Clinical Laboratory Diagnostic Market
3.1.5.18 Norwegian Clinical Laboratory Diagnostic Market
3.1.5.19 Irish Clinical Laboratory Diagnostic Market
3.1.5.20 Hungarian Clinical Laboratory Diagnostic Market
3.1.5.21 Bulgarian Clinical Laboratory Diagnostic Market
3.1.5.22 Slovakian Clinical Laboratory Diagnostic Market
3.1.5.23 Lithuanian Clinical Laboratory Diagnostic Market
3.1.5.24 Latvian Clinical Laboratory Diagnostic Market
3.1.5.25 Estonian Clinical Laboratory Diagnostic Market
3.1.5.26 Slovenian Clinical Laboratory Diagnostic Market
3.1.6 Asian Markets
3.1.6.1 Indian Clinical Laboratory Diagnostic Market
3.1.6.1.1 Indian IVD Testing Industry
3.1.6.2 Japanese Clinical Laboratory Testing Market
3.1.6.3 Chinese Clinical Laboratory Market
3.1.7 Clinical Laboratory Smaller Country Markets
3.1.7.1 Canadian Clinical Laboratory Market
3.1.7.2 Brazilian Clinical Laboratory Market
3.1.7.3 Australian Clinical Laboratory Market
3.1.8 ROW Clinical Laboratory Testing Market
3.1.9 Overview of Asian Healthcare Market
3.1.9.1 Singapore
3.1.9.2 Malaysia
3.1.9.3 Thailand
3.1.9.4 Indonesia
3.1.9.5 Philippines
3.1.9.6 South Korea
3.1.9.7 India
3.1.9.8 Hong Kong
3.1.9.9 Taiwan
3.1.10 Overview of the Latin American Diagnostics Market
3.2 Clinical Laboratory Sector
3.2.1 Worldwide IVD Sales
3.2.1.1 POLs
3.2.2 Industry Players
3.2.2.1 Manufacturing Companies
3.2.3 Market Specialization
3.2.4 Revenue and Reimbursement
3.2.5 Companies
3.3 Outlook for Clinical Laboratory Testing
3.3.1 Long-Term Changes
3.3.2 Market Drivers
3.3.3 The Limits to Growth
3.3.4 Hot Sectors in the IVD Market
3.3.5 Key Technologies
3.3.6 Conclusion

4. Clinical Laboratory Instrument Market by Sector
4.1 Chemistry Analyzers
4.1.1 Ultra-Large Throughput Laboratory Analyzers
4.1.2 Large-Throughput Analyzers
4.1.3 Mid-Size Clinical Laboratory Analyzers
4.1.4 Laboratory Analyzers for the Small Volume Market
4.2 Immunochemistry Analyzers
4.2.1 Large Immunochemistry Analyzers
4.2.2 Small Immunoassay Analyzers
4.3 Hematology Analyzers
4.4 POCT
4.4.1 U.S. POC Markets
4.4.2 European POCT Market
4.4.2.1 German POC Diagnostic Markets
4.4.2.2 U.K. POCT Diagnostic Market
4.4.2.2.1 U.K. Market Statistics
4.4.2.2.2 U.K. Competitive Analysis
4.4.2.2.3 U.K. Market Access
4.4.2.3 French POC Diagnostic Market
4.4.2.4 Italian POC Diagnostic Market
4.4.2.5 Spanish POC Diagnostic Market
4.4.2.6 Scandinavian POC Market
4.4.3 Japanese POCT Market
4.4.4 Chinese POC Market
4.4.5 Canadian POC Market
4.4.6 Brazilian POC Market
4.4.7 Turkish POC Market
4.4.8 Australian POC Market
4.5 ROW POCT Market
4.6 Cytology Testing
4.7 Microbiology Testing
4.8 Serology Testing
4.9 Esoteric Testing
4.10 Anatomic Pathology
4.11 Drug Testing

5. Important Technology Trends in IVD Instrumentation and Reagents
5.1 Technology Innovations in Instrument and Reagent Development
5.2 Sensor Systems for Diagnostic Applications
5.3 Glucose Measurements
5.4 Glucose Test Methods
5.5 Cholesterol Measurements
5.6 The New Paradigm
5.7 Consolidated Workstations
5.8 Automation in the Laboratory
5.9 Laboratory Information Systems
5.10 New User-friendly Interfaces
5.11 Biosensor Technology
5.12 Data-Management Issues
5.12.1 Wireless LANs
5.12.2 Cepheid’s POC GBS and BCR/ABL Tests
5.12.3 Data and Workflow Management Systems
5.12.4 Beckman Central Command

6. Business Trends in the Clinical Laboratory Analyzer and Reagents Market
6.1 Key Market Developments
6.1.1 Decreasing Revenue from Traditional IVD Markets
6.1.2 High Growth in POCT and Molecular Diagnostics Arena
6.1.3 Move Away from Traditional Kit Testing Methods
6.1.4 Integrated Analytical Systems
6.1.5 Regulatory Changes
6.1.6 Development of a Two-Tier Industry Structure
6.1.7 Labor Costs
6.1.8 Increasing Value of Companies with High-Margin Technology Platforms
6.1.9 The Joining of IVD Testing and Computer Technology
6.1.10 User-Friendly User Interfaces
6.2 Sector Consolidation
6.2.1 IVD Company Consolidation
6.2.2 Lab Company Consolidation
6.2.2.1 Acquisition Pricing
6.2.2.2 A Closer Look at Six Big Lab Deals
6.3 Diagnostic Testing Growth Trends
6.4 Reagent and Hardware Business in Japan
6.5 New Products
6.6 Acquisition, License Agreements, Internal Development and Partnerships
6.7 Product Testing Depth in Clinical Laboratory Testing
6.8 Government Regulation of IVD Devices
6.8.1 U.S. Regulation
6.8.1.1 Importing Medical Devices into the U.S.
6.8.1.2 Exporting Medical Devices from the U.S.
6.8.2 U.K. Regulation
6.8.3 E.U. Regulation
6.8.3.1 France
6.8.4 Japanese Regulation
6.8.5 Korean Regulation
6.8.6 Chinese Regulation
6.9 Increased Market Penetration
6.10 Costs of Doing Business in Europe
6.11 Drivers of European Diagnostics Testing
6.12 European Reimbursement Practices
6.13 Cost Containment in Europe
6.14 Hospital Outreach Programs
6.15 Electronic Procurement: New Challenges
6.16 Competition for Supply Chain Management Solutions
6.17 E-Commerce in the Hospital Supply Chain
6.17.1 Drivers of E-Commerce Solutions
6.17.2 Barriers to E-Commerce Solutions
6.18 Top Trends in Laboratory Business Practices
6.19 The Value of the New Diagnostics
6.20 Converging Technologies-Drugs and Diagnostic Tests Combine for Improved Healthcare
6.21 Emerging Technologies in the Downstream Manufacture of Bio-Materials
6.22 GMP Readiness
6.23 Harnessing Human Resource Capabilities and IT Prowess: Biotechnology in the Future
6.24 Partnering with Patient-Based Organizations to Achieve Patient Health Goals
6.25 Rumors of the Platform Company’s Demise are Greatly Exaggerated
6.26 Who’s Going to Pay for It?

7. Company Profiles
7.1 Abaxis
7.2 Abbott Diagnostics
7.3 Adaltis, Inc.
7.4 Alfa Wasserman, Inc. (formerly Electro-Nucleonics, Inc. and Schiapparelli Biosystems, Inc.)
7.5 Awareness Technology
7.6 Bayer Diagnostics
7.7 Beckman Coulter, Inc.
7.8 Bio-Reference Laboratories, Inc.
7.9 Clarient, Inc.
7.10 Dade Behring, Inc.
7.11 Enzo Biochem, Inc.
7.12 Genomic Health, Inc.
7.13 Hitachi
7.14 Horiba Ltd.
7.15 JEOL Ltd.
7.16 LabCorp
7.17 Medtox Scientific, Inc.
7.18 Monogram Biosciences, Inc.
7.19 Myriad Genetics, Inc.
7.20 Nova Biomedical
7.21 Olympus America, Inc. Diagnostic Systems Division
7.22 Ortho-Clinical Diagnostics, a J&J Company
7.23 Psychemedics Corporation
7.24 Quest Diagnostics, Inc.
7.25 Roche Diagnostics Corp.
7.26 Shimadzu
7.27 Sysmex Corporation
7.28 Thermo Fisher Scientific, Inc.
7.29 Vital Scientific, NV

LIST OF FIGURES

Figure 2.1: Clinical Laboratory Testing Sector Providers
Figure 2.2: Part B Spending on Clinical Laboratory Services, 1991-2005
Figure 3.1: European IVD Market by Clinical Specialty
Figure 3.2: Chinese IVD Market, 1995-2004
Figure 3.3: Annual Worldwide IVD Market Growth, 2003-2005
Figure 3.4: POL Revenue, 2000-2006
Figure 3.5: Unweighted Average Medicare Reimbursement for Ten Most Common POL Tests, 2002 vs. 2006
Figure 3.6: Total Number of Non-Waived POLs, 2000-2006
Figure 3.7: Number of New Tests Granted CLIA-Waived Status, 2000-2006
Figure 3.8: High-Volume Waived Tests
Figure 3.9: U.S. Revenue for Six Largest IVD Vendors, 2005
Figure 3.10: U.S. Revenue Change for Six Largest IVD Vendors, 2005
Figure 6.1: Average Revenue-Multiple Paid to Acquire Labs, 2000-2006
Figure 6.2: Hospital Market Share for Outreach Programs

LIST OF TABLES

Table 2.1: Total U.S. Clinical Laboratory Revenue from Third Party and Direct Payment, 2005-2012
Table 2.2: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2005
Table 2.3: Independent Commercial Laboratory Testing Market Value, 2005-2012
Table 2.4: Independent Commercial Laboratory Testing Test Volume, 2005-2012
Table 2.5: Leading U.S. Reference Laboratories Grouped by Market Capitalization, 2006
Table 2.6: Revenue Growth at Quest Diagnostics, 2000-2006
Table 2.7: Revenue Growth at LabCorp, 2000-2006
Table 2.8: Quest Diagnostics Revenue from Managed Care Contracts, 2004-2006
Table 2.9: LabCorp Revenue from Managed Care Contracts, 2004-2006
Table 2.10: Quest’s Total Volume of Requisitions and Net Revenues from Clinical Laboratory Testing, 2005
Table 2.11: Number of Hospital Based Clinical Laboratory Tests in the U.S., 2002-2008
Table 2.12: European Cardiovascular Disease Management Expenditures, 2003-2010
Table 2.13: U.S. Doctor’s Office Lab Test Dollar Volume and Growth Rates, 2006
Table 2.14: Worldwide Alternate Site Clinical Lab Instrument and Reagents Sales, 2005-2012
Table 2.15: Top IVD Manufacturers, 2005
Table 2.16: Products Marketed by Abbott in the Diagnostic Market
Table 2.17: Prodesse’s ASRs
Table 2.18: Hospital Laboratory Share of Part B Medicare Spending, 1996-2005
Table 2.19: Medicare Spending on Clinical Lab Services, 1991-2005
Table 2.20: Medicare Part B Spending Per Medicare Enrollee, 1998-2005
Table 2.21: Allowed Charges for Top 25 Clinical Laboratory Procedures, 2005
Table 3.1: Worldwide IVD Testing Market, 2006
Table 3.2: Worldwide Distribution of IVD Testing, 2006
Table 3.3: Global Clinical Laboratory Market Sales, 1998-2010
Table 3.4: Top 15 IVD Manufacturers’ Worldwide Revenue
Table 3.5: U.S. Clinical Laboratory Testing Market, 2003-2012
Table 3.6: U.S. Clinical Laboratory Diagnostic Test Market Segments, 2006
Table 3.7: U.S. Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by Analyte, 2006
Table 3.8: U.S. Individual Clinical Chemistry Laboratory Diagnostic Test Markets, 2006
Table 3.9: European Clinical Laboratory Testing IVD Reagents and Instruments Market, 2000-2012
Table 3.10: European Clinical Laboratory Diagnostic Testing Reagents and Instruments Market by Analyte, 2006
Table 3.11: European Clinical Chemistry Testing Reagents and Instruments Market, 2006
Table 3.12: European Clinical Laboratory Testing Diagnostics by Country Market, 2006
Table 3.13: European Rapid POCT by Country Market, 2006
Table 3.14: European Patient Self Testing OTC Diagnostics by Country Market, 2006
Table 3.15: German Clinical Laboratory Testing Diagnostics Products Market Sales, 2003-2012
Table 3.16: German Clinical Reagents and Instruments Market, 2003
Table 3.17: U.K. Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.18: U.K. Clinical Reagents and Instruments Market, 2006
Table 3.19: Major U.K. IVD Manufacturers
Table 3.20: U.S. IVD Manufacturers Doing Business in the U.K.
Table 3.21: Other European Companies that Manufacture IVD Products in the U.K.
Table 3.22: French Clinical IVD Testing Diagnostics Products Market Sales, 2003-2012
Table 3.23: French Clinical Reagents and Instruments Market, 2006
Table 3.24: Italian Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.25: Italian Clinical Reagents and Instruments Market, 2006
Table 3.26: Spanish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.27: Spanish Clinical Reagents and Instruments Market, 2006
Table 3.28: Finnish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.29: Finnish Clinical Reagents and Instruments Market, 2006
Table 3.30: Turkish Clinical Laboratory Testing Market, 2003-2012
Table 3.31: Belgium Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.32: Belgium Clinical Reagents and Instruments Market, 2006
Table 3.33: Swiss Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.34: Swiss Clinical Reagents and Instruments Market, 2006
Table 3.35: Dutch Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.36: Dutch Clinical Reagents and Instruments Market, 2006
Table 3.37: Portuguese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.38: Portuguese Clinical Reagents and Instruments Market, 2006
Table 3.39: Austrian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.40: Austrian Clinical Reagents and Instruments Market, 2006
Table 3.41: Greek Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.42: Greek Clinical Reagents and Instruments Market, 2006
Table 3.43: Polish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.44: Polish Clinical Reagents and Instruments Market, 2006
Table 3.45: Romanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.46: Romanian Clinical Reagents and Instruments Market, 2006
Table 3.47: Czech Republic Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.48: Swedish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.49: Norwegian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.50: Irish Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.51: Hungarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.52: Bulgarian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.53: Slovakian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.54: Lithuanian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.55: Latvian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.56: Estonian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.57: Slovenian Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.58: Indian IVD Market for Instruments and Reagents, 2004-2012
Table 3.59: Number of Automated Clinical Labs in India, 2004-2012
Table 3.60: Indian IVD Market, 2006
Table 3.61: Market Sales of IVD Equipment and Reagents by Company in India, 2004 and 2005
Table 3.62: Japanese Clinical Laboratory Testing Instrument and Reagents Market, 2003-2012
Table 3.63: Chinese Clinical Laboratory Diagnostics Products Market Sales, 2003-2012
Table 3.64: Chinese IVD Market
Table 3.65: Proportion of Medical Expenses Paid Privately
Table 3.66: Chinese International IVD Manufacturers
Table 3.67: Chinese Domestic IVD Manufacturers
Table 3.68: Chinese IVD Distributors
Table 3.69: Canadian Clinical Laboratory Testing Market, 2000-2008
Table 3.70: Brazilian Clinical Laboratory Testing Market, 2000-2008
Table 3.71: Australian Clinical Laboratory Testing Market, 2000-2008
Table 3.72: ROW Clinical Laboratory Testing Market, 2000-2008
Table 3.73: Number of Clinical Laboratories in Latin America
Table 3.74: Twenty Most Common Laboratory Tests Offered at Family Physician Offices
Table 3.75: Important New Waived Tests
Table 3.76: Principal Marketers of Automated Clinical Laboratory Instruments
Table 4.1: Ultra-Large Clinical Laboratory Analyzers
Table 4.2: JEOL Analyzer Comparison
Table 4.3: Large Clinical Laboratory Analyzers
Table 4.4: Mid-size Clinical Laboratory Analyzers
Table 4.5: Small Clinical Laboratory Analyzers
Table 4.6: Large Immunochemistry Analyzers
Table 4.7: Small Immunoassay Analyzers
Table 4.8: Linearity and Precision of Abbott CELL-DYN Hematology Analyzers
Table 4.9: Accuracy of the Automated Differential of Abbott CELL-DYN Analyzers
Table 4.10: Linearity and Precision of Bayer Hematology Analyzers
Table 4.11: Accuracy of the Automated Differential of Bayer Hematology Analyzers
Table 4.12: Linearity and Precision of Beckman Coulter Hematology Instruments
Table 4.13: Accuracy of the Automated Differential of Beckman Coulter Hematology Analyzers
Table 4.14: Linearity and Precision of Horiba ABX Hematology Analyzers
Table 4.15: Accuracy of the Horiba ABX Hematology Analyzers
Table 4.16: Linearity and Precision of Sysmex Hematology Analyzers
Table 4.17: Accuracy of the Sysmex Hematology Analyzers
Table 4.18: Comparison of Linearity and Precision of Top-of-the-Line Hematology Analyzers
Table 4.19: Comparison of Accuracy of the Top-of-the-Line Hematology Analyzers
Table 4.20: Hematology Analyzers with a Five-Part WBC Differential
Table 4.21: Hematology Analyzers with a Three-Part WBC Differential
Table 4.22: POCT
Table 4.23: Number of ER Visits in U.S. Hospitals, 1996-2005
Table 4.24: Number of POCT in U.S., 2000-2011
Table 4.25: Global POC Revenues, 1998-2008
Table 4.26: Worldwide Distribution of POCT, 2005
Table 4.27: U.S. POCT Market, 2000-2011
Table 4.28: U.S. Clinical Diagnostic Test Market Segments, Revenue from Clinical Laboratory Testing, 2005
Table 4.29: U.S. POCT by Distribution Location, 2005
Table 4.30: U.S. Clinical Diagnostic POCT and Rapid Test Market Segments, 2005
Table 4.31: Drivers of European Diagnostics Testing
Table 4.32: Regional Comparison of Healthcare and IVD for Eastern Europe
Table 4.33: European IVD Reagent Testing Market, 2000-2012
Table 4.34: European Testing Diagnostics Market, 2004
Table 4.35: Top Dozen Country IVD Testing Markets and POC Share, 2004
Table 4.36: German POCT Diagnostics Products Market Sales, 2002-2007
Table 4.37: German Patient Care Central Lab Test Market, 2000-2008
Table 4.38: German Alternate Site Testing Market (POL), 2000-2008
Table 4.39: German Hospital POC Market, 2000-2008
Table 4.40: German Clinical Diagnostic Test Market Segments; Sales from Clinical Laboratory Testing, 2004
Table 4.41: German Clinical Diagnostic Rapid Test Market Segments
Table 4.42: U.K. POC Diagnostics Products Market Sales, 1998-2007
Table 4.43: Major U.K. IVD Manufacturers
Table 4.44: U.S. IVD Manufacturers Doing Business in the U.K.
Table 4.45: Other European Companies that Manufacture IVD Products in the U.K.
Table 4.46: French POC Diagnostics Products Market Sales, 1998-2007
Table 4.47: Italian POC Diagnostics Products Market Sales, 1998-2007
Table 4.48: Spanish POC Diagnostics Products Market Sales, 1998-2007
Table 4.49: Scandinavian POC Diagnostics Products Market Sales, 2000-2008
Table 4.50: Japanese POCT Market, 2000-2008
Table 4.51: Chinese POC Diagnostics Products Market Sales, 2000-2008
Table 4.52: Canadian POCT Market, 2000-2008
Table 4.53: Brazilian POCT Market, 2000-2008
Table 4.54: Turkish POCT Market, 2000-2008
Table 4.55: Australian POCT Market, 2000-2008
Table 4.56: ROW POCT Market, 2000-2007
Table 4.57: PAP Tests in Top European Markets
Table 4.58: PAP Tests in Top Asian Markets
Table 5.1: Normal Glucose Values-Fasting State
Table 5.2: Applications for Wireless LAN Technology
Table 7.1: Products Marketed by Abbott in the Diagnostics Market
Table 7.2: Products Marketed by Dade Behring in the Diagnostics Market
Table 7.3: Clinically Significant Tests Available From Dade
Table 7.4: Comparison of JEOL Analyzers
Table 7.5: The VITROS ECiQ Immunodiagnostic System
Table 7.6: Sysmex Marketing Summary for China